Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening

Study summary

The purpose of this project is to increase appropriate low-dose computed tomography (LDCT) lung cancer screening through the development and wide dissemination of patient-centered clinical decision support (CDS) tools that (1) are integrated with the electronic health record (EHR) and clinical workflows, (2) prompt for shared decision making (SDM) when patients meet screening criteria, and (3) enable effective SDM using individually-tailored information on the potential benefits and harms of screening. The study will promote standard of care that is endorsed by the Centers for Medicare \& Medicaid Services (CMS) and the US Preventive Services Task Force (USPSTF).

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedEHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening

The study team can explain what participation involves.

Who it may be forEarly Detection of Cancer · Lung Neoplasms

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 24, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Utah

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: University of Utah
Interventions being studied: Other: EHR-integrated Shared Decision Making Tool and Clinical Decision Support for Lung Cancer Screening

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

receives care at University of Utah primary care clinics;
does not already have lung cancer;
meets USPSTF criteria for LDCT screening (currently, age \>= 55 years and \<= 80 years old at the time of the visit; 30+ pack-year smoking history and current smoker or quit in the past 15 years).

Reasons someone may not be able to joinExclusion criteria

None

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of Utah HealthSalt Lake City, Utah

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 24, 2025. Always confirm current availability with the study team.

View original record ↗